News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Names Daniel J. Walsh to Lead New Ethics and Compliance Post
05/12/2005

DUBLIN, Ohio, May 11, 2005 - Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health-care industry, today named Daniel J. Walsh to the new post of executive vice president and chief ethics and compliance officer, reporting to both Robert D. Walter, chairman and chief executive officer, and the audit committee of Cardinal Health's board.

Since 2003, Walsh, 49, has been vice president and chief compliance officer at the Atlanta-based Scientific-Atlanta, Inc., where he was responsible for the creation and oversight of a broad corporate compliance program incorporating best practices in education, policy, hotline administration and compliance monitoring.

"Cardinal Health has longstanding structures in place to promote compliance, but Dan's appointment underlines our commitment to the highest standards of ethics, integrity and compliance," said Walter. "The exemplary work he has done throughout his career will serve as a model for us."

From 1993 to 2003, Walsh was corporate compliance officer serving in the New York, London and Washington, D.C. offices of Smiths Group PLC, a global provider of medical, industrial and aerospace products. From 1986 to 1993, he was a director and senior manager in the management consulting division of PricewaterhouseCoopers' New York and Washington, D.C. offices. Earlier, he held compliance and auditing positions at the Loral Corporation and for the U.S. Department of Defense.

Walsh earned a Master of Business Administration degree in executive management from New York's St. John's University and is licensed in New York as a certified public accountant.

Walsh joins Cardinal Health on May 18. As part of his duties, he will be a member of Cardinal Health's executive committee, disclosure committee and will chair the corporate responsibility committee.

About Cardinal Health
Cardinal Health, Inc. (www.cardinalhealth.com) is the leading provider of products and services supporting the health care industry. Cardinal Health develops, manufactures, packages and markets products for patient care; develops drug-delivery technologies; distributes pharmaceuticals, medical- surgical and laboratory supplies; and offers consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, Cardinal Health employs more than 55,000 people on six continents and produces annual revenues of more than $65 billion.

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields